2017 Paris to Ancaster

Team Scleroderma Research

The Hamilton Scleroderma Group is comprised of specialists, researchers, and students dedicated to the care of patients with scleroderma. Through tremendous funding from the Scleroderma Society of Ontario we exist to improve access to clinical care, enhance education and awareness and increase basic science and clinical research.

Systemic Sclerosis (scleroderma) is a rare but serious progressive autoimmune connective tissue disease that affects small blood vessels and causes excess collagen accumulation. This can lead to tightening of the skin and scarring of the internal organs. Many patients experience severe symptoms of fatigue, pain, and loss of independence.

Currently, there is no cure for scleroderma and treatment options remain limited. We are determined to change that! 

Last year, the Hamilton Scleroderma Group put together a team of 20 cyclists who participated in St Joes Foundation Paris to Ancaster Bike ride. Through this ride, we raised just over $10,000 which turned into $60,000 after matching from other scholarships!

Those funds will be used to have 4 graduate students working on systemic sclerosis or fibrosis or other connective tissue disease over the next 4 years. These studentships are invaluable to continuing the research work of the Hamilton Scleroderma Group and getting closer to understanding the mechanisms behind the disease, which in turn will allow for the development of therapies.

This year, we are excited to bring back Team Scleroderma Research!

Please join us in our relentless efforts to find better treatments for Scleroderma!


View More